• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PhID:一个关于药物、靶点、疾病、基因、副作用和通路的开放获取综合药理学相互作用数据库。

PhID: An Open-Access Integrated Pharmacology Interactions Database for Drugs, Targets, Diseases, Genes, Side-Effects, and Pathways.

作者信息

Deng Zhe, Tu Weizhong, Deng Zixin, Hu Qian-Nan

机构信息

Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, and Wuhan University School of Pharmaceutical Sciences , Wuhan, 430071, China.

Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences , 300308, Tianjin, China.

出版信息

J Chem Inf Model. 2017 Oct 23;57(10):2395-2400. doi: 10.1021/acs.jcim.7b00175. Epub 2017 Oct 12.

DOI:10.1021/acs.jcim.7b00175
PMID:28906116
Abstract

The current network pharmacology study encountered a bottleneck with a lot of public data scattered in different databases. There is a lack of an open-access and consolidated platform that integrates this information for systemic research. To address this issue, we have developed PhID, an integrated pharmacology database which integrates >400 000 pharmacology elements (drug, target, disease, gene, side-effect, and pathway) and >200 000 element interactions in branches of public databases. PhID has three major applications: (1) assisting scientists searching through the overwhelming amount of pharmacology element interaction data by names, public IDs, molecule structures, or molecular substructures; (2) helping visualizing pharmacology elements and their interactions with a web-based network graph; and (3) providing prediction of drug-target interactions through two modules: PreDPI-ki and FIM, by which users can predict drug-target interactions of PhID entities or some drug-target pairs of their own interest. To get a systems-level understanding of drug action and disease complexity, PhID as a network pharmacology tool was established from the perspective of data layer, visualization layer, and prediction model layer to present information untapped by current databases.

摘要

当前的网络药理学研究遇到了瓶颈,大量公共数据分散在不同的数据库中。缺乏一个开放获取且整合的平台来整合这些信息以进行系统研究。为了解决这个问题,我们开发了PhID,一个整合药理学数据库,它整合了超过40万个药理学元素(药物、靶点、疾病、基因、副作用和通路)以及公共数据库分支中的超过20万个元素相互作用。PhID有三个主要应用:(1)帮助科学家通过名称、公共ID、分子结构或分子亚结构在海量的药理学元素相互作用数据中进行搜索;(2)通过基于网络的网络图帮助可视化药理学元素及其相互作用;(3)通过两个模块PreDPI-ki和FIM提供药物-靶点相互作用的预测,用户可以通过这两个模块预测PhID实体的药物-靶点相互作用或他们感兴趣的一些药物-靶点对。为了从系统层面理解药物作用和疾病复杂性,PhID作为一个网络药理学工具,从数据层、可视化层和预测模型层的角度建立起来,以呈现当前数据库未挖掘的信息。

相似文献

1
PhID: An Open-Access Integrated Pharmacology Interactions Database for Drugs, Targets, Diseases, Genes, Side-Effects, and Pathways.PhID:一个关于药物、靶点、疾病、基因、副作用和通路的开放获取综合药理学相互作用数据库。
J Chem Inf Model. 2017 Oct 23;57(10):2395-2400. doi: 10.1021/acs.jcim.7b00175. Epub 2017 Oct 12.
2
Updates on drug-target network; facilitating polypharmacology and data integration by growth of DrugBank database.药物-靶点网络的更新;通过DrugBank数据库的增长促进多药理学和数据整合。
Brief Bioinform. 2016 Nov;17(6):1070-1080. doi: 10.1093/bib/bbv094. Epub 2015 Oct 21.
3
Visualization of drug target interactions in the contexts of pathways and networks with ReactomeFIViz.使用ReactomeFIViz在通路和网络背景下可视化药物靶点相互作用。
F1000Res. 2019 Jun 20;8:908. doi: 10.12688/f1000research.19592.1. eCollection 2019.
4
Using quantitative systems pharmacology for novel drug discovery.运用定量系统药理学进行新药研发。
Expert Opin Drug Discov. 2015 Dec;10(12):1315-31. doi: 10.1517/17460441.2015.1082543. Epub 2015 Aug 25.
5
GraphSAW: a web-based system for graphical analysis of drug interactions and side effects using pharmaceutical and molecular data.GraphSAW:一个基于网络的系统,用于利用药物和分子数据对药物相互作用及副作用进行图形化分析。
BMC Med Inform Decis Mak. 2015 Feb 28;15:15. doi: 10.1186/s12911-015-0139-5.
6
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.DrugGenEx-Net:一种用于基于系统药理学和基因表达的药物重新利用的新型计算平台。
BMC Bioinformatics. 2016 May 5;17(1):202. doi: 10.1186/s12859-016-1065-y.
7
Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases.系统药理学在药物发现中的策略及在心血管疾病中的应用。
J Ethnopharmacol. 2014;151(1):93-107. doi: 10.1016/j.jep.2013.07.001. Epub 2013 Jul 9.
8
Improving drug safety with a systems pharmacology approach.采用系统药理学方法提高药物安全性。
Eur J Pharm Sci. 2016 Oct 30;94:84-92. doi: 10.1016/j.ejps.2016.06.009. Epub 2016 Jun 7.
9
Systems pharmacology to predict drug safety in drug development.用于预测药物研发中药物安全性的系统药理学。
Eur J Pharm Sci. 2016 Oct 30;94:93-95. doi: 10.1016/j.ejps.2016.05.027. Epub 2016 May 29.
10
Identifying adverse drug reactions and drug-induced diseases using network-based drug mapping.使用基于网络的药物图谱识别药物不良反应和药物诱发疾病。
J Bioinform Comput Biol. 2015 Feb;13(1):1540007. doi: 10.1142/S0219720015400077.

引用本文的文献

1
Revealing the efficacy-toxicity relationship of Fuzi in treating rheumatoid arthritis by systems pharmacology.系统药理学揭示附子治疗类风湿关节炎的疗效-毒性关系。
Sci Rep. 2021 Nov 29;11(1):23083. doi: 10.1038/s41598-021-02167-5.
2
Systems pharmacology reveals the unique mechanism features of Shenzhu Capsule for treatment of ulcerative colitis in comparison with synthetic drugs.系统药理学揭示了参术胶囊与合成药物治疗溃疡性结肠炎的独特机制特征。
Sci Rep. 2018 Nov 1;8(1):16160. doi: 10.1038/s41598-018-34509-1.